These are top 10 stocks traded on the Robinhood UK platform in July
Investing.com - UBS has raised its price target on Cosmecca Korea Co (KS:241710) to KRW104,000 from KRW74,000 while maintaining a Buy rating.
The firm expects Cosmecca’s revenue and operating profit to grow quarter-over-quarter from Q2 2025, with earnings momentum accelerating in the second half of 2025.
UBS notes that Cosmecca plans to penetrate major offline channels in the U.S., including Ulta and Walmart (NYSE:WMT), starting in the second half of 2025, which should lead to increased orders beginning in Q2 2025.
Despite tariff concerns, UBS believes Cosmecca’s key clients have flexibility in accepting price increases and shifting production bases, while mix improvement from growing high-margin product sales, such as over-the-counter items including suncare, remains supportive.
The firm projects Cosmecca’s 2024-2029 sales and operating profit to grow at compound annual growth rates of 12% and 15%, respectively, driven by client base diversification, successful product launches, regional expansion, and new order flow at overseas plants.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.